文献速递肾癌与肾肿瘤

肾细胞癌的流行病学

Epidemiology of Renal Cell Carcinoma.
PubMed 文献 · Eur Urol · 2018-09-19

本文综述全球肾细胞癌(RCC)的发病率与死亡率差异,分析已知风险因素的强度,并探讨筛查与疾病管理的临床启示。RCC发病率存在地域异质性,吸烟、肥胖、高血压及慢性肾病为确立的风险因素,高危人群筛查的成本效益需按国家评估,因RCC总体发生率低,准确生物标志物的应用显得必要。

要点

  • RCC发病率与死亡率在全球不同国家和区域间存在显著差异。
  • 吸烟、肥胖、高血压和慢性肾病是已确立的RCC风险因素。
  • 高危人群筛查项目的成本效益需根据各国发病率、死亡率及管理成本进行评估。

核心结论

  • RCC发病率在全球范围内存在差异,吸烟、肥胖和高血压与RCC关联最强。
  • 由于RCC发生率低,实施准确的生物标志物似乎是必要的。

研究设计与样本

  • 本综述首先检索并描述全球RCC发病率/死亡率,其次对已知风险因素的强度进行叙述性文献回顾,最后结合前两步数据阐述对RCC筛查的临床启示。

主要发现

  • RCC发病率与死亡率在不同国家和世界区域间存在显著差异。
  • 潜在RCC风险因素包括行为和环境因素、合并症及镇痛药。
  • 吸烟、肥胖、高血压和慢性肾病是已确立的风险因素,其他因素虽与RCC风险增加相关,但可能存在选择偏倚且结果存在争议。

临床怎么用

  • 在RCC高危个体中,筛查项目的成本效益需根据各国发病率与死亡率的地域异质性、成本及管理影响进行评估。
  • 由于RCC发生率低,应用准确的生物标志物似乎是必要的。

局限性

  • 其他风险因素与RCC风险的关联可能受选择偏倚影响,且报告结果存在争议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Despite the improvement in renal cell carcinoma (RCC) diagnosis and management observed during the last 2 decades, RCC remains one of the most lethal urological malignancies. With the expansion of routine imaging for many disorders, an increasing number of patients who harbour RCC are identified incidentally. OBJECTIVE: To summarise and compare RCC incidence and mortality rates, analyse the magnitude of risk factors, and interpret these epidemiological observations in the context of screening and disease management. EVIDENCE ACQUISITION: The primary objective of the current review was to retrieve and describe worldwide RCC incidence/mortality rates. Secondly, a narrative literature review about the magnitude of the known risk factors was performed. Finally, data retrieved from the first two steps were elaborated to define the clinical implications for RCC screening. EVIDENCE SYNTHESIS: RCC incidence and mortality significantly differ among individual countries and world regions. Potential RCC risk factors include behavioural and environmental factors, comorbidities, and analgesics. Smoking, obesity, hypertension, and chronic kidney disease represent established risk factors. Other factors have been associated with an increased RCC risk, although selection biases may be present and controversial results have been reported. CONCLUSIONS: Incidence of RCC varies worldwide. Within the several RCC risk factors identified, smoking, obesity, and hypertension are most strongly associated with RCC. In individuals at a higher risk of RCC, the cost effectiveness of a screening programme needs to be assessed on a country-specific level due to geographic heterogeneity in incidence and mortality rates, costs, and management implications. Owing to the low rates of RCC, implementation of accurate biomarkers appears to be mandatory. PATIENT SUMMARY: The probability of harbouring kidney cancer is higher in developed countries and among smokers, obese individuals, and individuals with hypertension.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Capitanio U, Bensalah K, Bex A, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2018. PMID: 30243799. doi:10.1016/j.eururo.2018.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。